Leiomyosarcoma

A Leiomyosarcoma is a type of cancer that starts in smooth muscle tissue. It can occur in the stomach, intestines, or uterus. It's a serious condition that needs treatment.

Condition

What people with Leiomyosarcoma report

Every report comes from a Lived member, sent anonymously.

Have you tried Adriamycin (Doxorubicin) for Leiomyosarcoma?

NameHow it went

About Leiomyosarcoma

What It Is

Leiomyosarcoma (often shortened to LMS) is a rare cancer that starts in smooth muscle. This is the muscle you don't consciously control: it lines the walls of the uterus, stomach, intestines, bladder and blood vessels, and keeps blood, food and other material moving through the body. Because smooth muscle is found in so many places, leiomyosarcoma can begin almost anywhere, but it is found most often in the uterus and in the abdomen, particularly the deep space at the back of the abdomen (the retroperitoneum). It can also start in the trunk, arms or legs. Leiomyosarcoma is one of the more common types of sarcoma, the broad family of cancers that begin in muscle, fat, blood vessels and other connective tissue rather than in the linings of organs. Most forms are aggressive, meaning they can grow quickly and spread through the bloodstream to other organs. One exception is leiomyosarcoma confined to the skin, which rarely spreads and usually does well with surgery alone. Leiomyosarcoma mostly affects adults; it is very rare in children.

Causes & Risk Factors

In most people, no cause is found, and leiomyosarcoma is not known to run in families. A small number of cases are linked to inherited conditions that raise the risk of several cancers, including Li-Fraumeni syndrome, hereditary retinoblastoma and neurofibromatosis type 1. Past radiation treatment to the area is another recognized risk factor. For leiomyosarcoma of the uterus, the known risk factors include earlier radiation therapy to the pelvis and treatment with tamoxifen, a hormone-blocking medicine used for breast cancer. Risk also rises with age. Having one of these factors does not mean someone will develop the disease, and most people diagnosed had none of them.

How It's Diagnosed

Symptoms depend on where the tumor is. A tumor near the surface may show up as a lump or swelling. One deep in the abdomen often causes nothing noticeable until it is large, when it may bring pain, a feeling of fullness, nausea or unintended weight loss. In the uterus, the usual signs are bleeding between periods or after menopause, pelvic pain or pressure, or needing to urinate often. Imaging such as CT, MRI and PET scans shows the size and location of the tumor and whether it has spread. Only a biopsy can confirm leiomyosarcoma, though: a sample of tissue, usually taken with a needle, is examined by a pathologist (a doctor who diagnoses disease from tissue under a microscope). Because leiomyosarcoma is uncommon and can resemble other tumors, a review of the slides by a pathologist experienced in sarcoma is often worthwhile. Uterine leiomyosarcoma is especially hard to spot before surgery because it can look and behave like a fibroid, the very common noncancerous muscle growth of the uterus. No current test reliably separates the two, and a Pap test does not detect it. This matters for fibroid surgery: the US Food and Drug Administration (FDA) warns that cutting a uterus into small pieces inside the body with a power morcellator, so it can be removed through small incisions, can spread a hidden sarcoma and worsen the outlook. The FDA recommends against that technique when cancer is suspected and in women over 50, and says it should be done only inside a containment bag when it is used.

Treatment Options

Surgery to remove the entire tumor is the main treatment and offers the best chance of cure. For uterine leiomyosarcoma, this usually means removing the uterus, and often the ovaries and fallopian tubes as well. When cancer cells are left behind, the risk of it returning in the same place or elsewhere in the body is higher. Because the operation and the overall plan are complex, care is best planned with a team experienced in sarcoma. Radiation therapy may be given before or after surgery to lower the chance of the tumor regrowing in the same area. Chemotherapy is mainly used when the tumor is large, cannot be fully removed or has spread. Doxorubicin, a long-used chemotherapy drug, is the usual starting point. In a 2024 trial, adding trabectedin (Yondelis) to doxorubicin and then continuing trabectedin alone helped people with advanced leiomyosarcoma live longer than doxorubicin by itself, at the cost of more side effects. Gemcitabine combined with docetaxel is another common option, and pazopanib, a targeted pill that blocks signals cancer cells need to grow, is another option for advanced disease. For uterine leiomyosarcoma whose cells carry hormone receptors, hormone-blocking treatment is sometimes an option. For advanced disease, treatment aims to help people live longer and to ease symptoms rather than to cure, so the choice often weighs time gained against side effects. Surgery can sometimes remove cancer that has spread to the lungs, and radiation can relieve symptoms such as pain. Clinical trials are an important option at any stage, since standard choices remain limited.

What to Expect

The outlook depends mostly on where the tumor started, its size and grade (how abnormal the cells look), whether it has spread and whether surgery removed all of it. A smaller tumor that is found early and completely removed can be cured. When the cancer is large or has already spread, treatment becomes harder and usually aims at control over months or years rather than cure. Leiomyosarcoma confined to the skin is the clear exception, with very good long-term results after removal. Because leiomyosarcoma can return, either in the same area or elsewhere in the body, follow-up continues after treatment ends. It involves regular check-ups and repeat scans, and the results guide whether further treatment is needed. Recovery from major abdominal or pelvic surgery takes weeks, and chemotherapy usually brings tiredness and a period when infections are more likely. Removing the uterus ends periods and the ability to become pregnant, and removing both ovaries before menopause brings on menopause symptoms. Since the disease is rare, many people travel to a sarcoma center for at least part of their care, and patient organizations focused on leiomyosarcoma can help with information and support.

When to Seek Help

See a clinician about a new lump or swelling that does not go away, and about abdominal pain or fullness that persists. Vaginal bleeding after menopause, or between periods, should always be checked; people taking tamoxifen should report any bleeding that is not a normal period as soon as possible. During chemotherapy, call your care team right away for a fever of 100.5°F (38°C) or higher or chills, because infections during treatment can become serious quickly. After treatment, contact your team about new pain, a cough or shortness of breath that does not settle, or any new lump, rather than waiting for the next scheduled scan.

Questions to Ask Your Doctor

  1. 1.Has a pathologist with sarcoma experience reviewed my biopsy, and what grade and subtype is the tumor?
  2. 2.Can all of the tumor be removed with surgery, and should my care be planned at a sarcoma center?
  3. 3.What would radiation or chemotherapy add in my situation, and what side effects should I expect?
  4. 4.How often will I need scans after treatment, and what signs of a return should I watch for?
  5. 5.Are there clinical trials that fit my type and stage of leiomyosarcoma?

Last reviewed • Oct 2026

Educational content, not medical advice.